Of importance, it has been reported that serum CIP2A levels positively associate with poor prognosis and aggressive breast cancer phenotypes [52], and it could also be of interest to analyze serum p-AKT levels in forthcoming studies. This evidence concerns the gene CIP2A and breast cancer.